TCL Archive FDA examining endpoints for approval of cancer therapies, potential departure from survival as the gold standard, Oncology Division Director Richard Pazdur says in interview. November 7, 2003
TCL Archive Institute Of Medicine Report Says Insurers Should Pay Patient Care Costs In Clinical Trials February 24, 1989